Search research articles
Contact Us
Filters
Showing results (121-130 of 129) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 129 results.
International Endodontic Journal
|
June 5, 2019
Perioperative dental screening and treatment in patients undergoing cardiothoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology
E Cotti, F Cairo, P P Bassareo, et al.
Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology
|
July 15, 2023
Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)
L Landi, P Tranquilli Leali, L Barbato, et al.
British Journal of Cancer
|
August 2, 2012
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
G Minuti, F Cappuzzo, R Duchnowska, et al.
British Journal of Cancer
|
October 29, 2014
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
A D'Incecco, M Andreozzi, V Ludovini, et al.
Biomarker Research
|
July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E Krasniqi, A Sacconi, D Marinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E Bajetta, I Floriani, M Di Bartolomeo, et al.
ESMO Open
|
June 19, 2021
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078]
G L Banna, A Cortellini, D L Cortinovis, et al.
ESMO Open
|
March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer
G L Banna, A Cortellini, D L Cortinovis, et al.
Studies in Mycology
|
August 5, 2024
What are the 100 most cited fungal genera?
C S Bhunjun, Y J Chen, C Phukhamsakda, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 129) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 129 results.
International Endodontic Journal
|
June 5, 2019
Perioperative dental screening and treatment in patients undergoing cardiothoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology
E Cotti, F Cairo, P P Bassareo, et al.
Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology
|
July 15, 2023
Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)
L Landi, P Tranquilli Leali, L Barbato, et al.
British Journal of Cancer
|
August 2, 2012
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
G Minuti, F Cappuzzo, R Duchnowska, et al.
British Journal of Cancer
|
October 29, 2014
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
A D'Incecco, M Andreozzi, V Ludovini, et al.
Biomarker Research
|
July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E Krasniqi, A Sacconi, D Marinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E Bajetta, I Floriani, M Di Bartolomeo, et al.
ESMO Open
|
June 19, 2021
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078]
G L Banna, A Cortellini, D L Cortinovis, et al.
ESMO Open
|
March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer
G L Banna, A Cortellini, D L Cortinovis, et al.
Studies in Mycology
|
August 5, 2024
What are the 100 most cited fungal genera?
C S Bhunjun, Y J Chen, C Phukhamsakda, et al.
Page
of 13